ERANET BiophotonicsPlus

ERANET BiophotonicsPlus

What is BiophotonicsPlus?

BiophotonicsPlus is a joint initiative to stimulate and fund R&D projects which will translate existing biophotonic technology and methods into appliances and put them into clinical, medical or industrial practice.  BiophotonicsPlus is supported by the European Commission, DG CONNECT under the ERANET-Plus scheme. However, it is not a FP7 call for proposals, but it is implemented under the responsibility of the participating countries and regions. Thus, specific rules for participation apply.

The BiophotonicsPlus competition will be open for applicants (legal entities) from the participating countries and regions:

Catalonia, Spain                      Latvia

Flanders, Belgium                   Tuscany, Italy

Germany                                   United Kingdom

Eligible project proposals comprise at least two participants (usually enterprises) from at least two participating countries and regions. Participants must be eligible according to the eligibility rules of their respective country or region.

The call text will be release on the competition website on October 1st 2012,

If you are seeking a partner for your project and/or looking to participate in a proposal there is a matchmaking page on the website,

Diary Dates

01st October 2012

Opening date for Pre-proposals


17th December 2012

Closing date for Pre-proposals


   January 2013

Feedback on eligibility from pre-proposals


09th April 2013

Closing date for Pre-proposals


 UK Participants Eligibility

Only UK Industrial partners [Large companies and SMEs] are eligible for funding from the Technology Strategy Board.  Academics are welcome to participate in projects but they have to self fund or secure funding from other sources prior to application.

  • UK Partner grant funding levels will be 50% of eligible costs.
  • All UK participants must be separate legal entities.
  • Companies with fewer than 5 Full Time staff cannot lead a project, unless agreed prior to application with the Technology Strategy Board.
  • Companies must have been trading for at least 12 months, be VAT registered and have to provide evidence they have the resources and finances to undertake the project.
  • Maximum total grant limit is €300,000 for all UK consortium partners in a single project
  • No single UK company can:
               1.     Receive more than €500,000 from the BiophotonicsPlus call budget.
               2.    Be a partner in more than 3 proposals for funding.
  • Subcontracting is limited to 20% of the UK partner grant.

 There are specific accountancy rules for Sole Traders & Micro Companies [companies with less than 10 employees].

Claims under the UK grant must be for project costs incurred in the UK; project management must be undertaken by a project participant and cannot be subcontracted.

Applications will be reviewed to identify if there are any obvious reasons for exclusion on the basis of national track record such as the participant having already received funding for the same or a very similar activity.

See Pdf on the eligible project costs for eligible costs for UK industrial partners.

For eligibility and operational questions contact,

 Graham M Mobbs
European Operations Manager
Technology Strategy Board
Tel:: +44 (0)7824 599585


For technical questions please contact,

 Myrddin Jones
Lead Technologist, Electronics, Photonics, Electrical Systems
Technology Strategy Board.
Tel:: +44 [0]7826 861153






Last updated on Tuesday 25 September 2012 at 14:29

Copyright © 2013